A Phase II Multicenter Randomized Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

UCI-14-24
NCT02008656
Cancer - Rectum
Joseph Carmichael
Open
Treatment
5-FU, Capecitabine, Eloxatin, Leucovorin, Oxaliplatin, Xeloda
Chemotherapy (NOS)
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.